Best Renal Transplant Doctors in Englewood, NJ

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Benjamin Samstein, MD is Chief of Liver Transplantation and Hepatobiliary Surgery in the Department of Surgery at NewYork-Presbyterian/Weill Cornell Medicine and Associate Professor of Surgery at Weill Cornell Medical College, Cornell University. Dr. Samstein is the Surgical Director of the Living Donor Liver Transplant Program at NYP. Dr. Samstein is a renowned pioneer in minimally invasive liver surgery and state-of-the-art laparoscopic techniques for liver cancer. Dr. Samstein is a Castle Connolly Top Doctor. Dr. Samstein heads up the multidisciplinary liver transplantation and hepatobiliary surgery team at NYP/Weill Cornell. His specialties include the most advanced laparoscopic procedures for liver cancer, benign liver tumors and hepatobiliary pancreatic disease. He has been invited to talk about minimally invasive liver surgery throughout the world. He is a member of many surgical societies including a founding member of the International Laparoscopic Liver Society (ILLS), American Society of Transplant Surgery, American Hepato-Pancreato-Biliary Association (AHPBA). He is the Chair of the Medical Advisory Board of LiveOnNY and served as the Regional representation to the Liver and Intestine Committee of UNOS from 2014 to 2016. Dr. Samstein is well-published in the field, authoring more than 40 peer-reviewed articles in prestigious medical and surgical journals, books and book chapters. Other areas of clinical expertise include hepatic adenoma, hepatic hemangioma, cholangiocarcinoma, colorectal metastasis, live donor nephrectomy, laparoscopic living donor nephrectomy, and pediatric liver and organ transplant. Dr. Samstein received his undergraduate degree from Cornell University in 1992 and earned his MD at the State University of New York at Stonybrook in 1997. He did his internship and residency in general surgery at NYP/Columbia, and completed a research fellowship at the Mayo Clinic in 2001. He completed a fellowship in ASTS Multi-organ transplant at NYP/Columbia in 2006. He was Assistant Professor of Surgery at Columbia University Medical Center from 2006 to 2015. He served as Program Director of the transplant surgery fellowship at Columbia University from 2007 to 2015. He is a reviewer for American Journal of Transplantation, Transplantation, Liver Transplantation, Pediatric Transplantation, Clinical Transplantation among other journals. List of Publications by Dr. Samstein PubMed

Dr. Sandip Kapur is Chief of Transplant Surgery and Director of the Kidney and Pancreas Transplant Programs at NewYork-Presbyterian/Weill Cornell Medical Center. An internationally recognized expert in pioneering transplant techniques, Dr. Kapur specializes in adult and pediatric kidney transplantation and whole organ pancreas and islet cell transplantation. Dr. Kapur was named as one of "America's Top Doctors" by both US News World Report and Castle Connolly in 2011, 2012 and 2013. He was cited every year since 2010 as a "New York SuperDoctor," an honor accorded just 5% of all New York physicians.

I relate well to children of all ages in a non-threatening way. I will explain your child's condition in terms you can understand, and I will make sure that you understand all of the treatment options, including non-surgical options. I will answer all of your questions, and will make myself available to you, if you should have more questions after you leave. You will leave my office feeling educated and empowered. I will offer your child the latest in minimally invasive techniques, with minimal pain and scarring, and faster recovery. I love my patients and treat them as if they were my own, and I take pride in my craft.

Click here to view New York Times article on Dr. Michelassi's strictureplasty for crohns disease.

Dr. Hiroo Takayamais Chief of Adult Cardiac Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. He has more than 20 years of experience in treating patients with heart and vascular problems. As the Director of the Aortic Surgery Program and co-Director of the Aortic Center, the Hypertrophic Cardiomyopathy Center, and the Marfan Clinic at NYP/Columbia, Dr. Takayama has contributed to the care of over 4,000 patients by performing a variety of aortic and cardiac surgical procedures, approximately 300-350 operations every year. Dr. Takayama is internationally recognized for his work on complex aortic surgery (minimally invasive aortic surgery, valve-sparing aortic root replacement, aortic valve repair, aortic arch and thoracoabdominal aneurysm repair), hybrid aortic surgery (thoracic endovascular aneurysm repair), myectomy for obstructive hypertrophic cardiomyopathy, and heart failure surgery. He is a leader in outcome research in aortic diseases and heart failure. He has published more than 300-350 manuscripts in prestigious, peer-reviewed journals and has authored numerous book chapters about heart disease. Dr. Takayama attended University of Tokyo for Medical School, did his internship at University of Tokyo, general surgery residency in University of Washington Medical Center, and cardio-thoracic surgery fellowship in New-York Presbyterian/Columbia University Medical Center.

As a board-certified surgeon with clinical expertise in vascular and endovascular surgery, it is my mission to provide compassionate patient care and offer state-of-the-art treatment options for the full spectrum of vascular disease. My experience with both complex open operations as well as advanced endovascular procedures allows me to develop individualized surgical plans that best meet the needs of each patient. Using cutting edge technology, I offer minimally invasive surgical approaches aimed at reducing post-operative pain, scarring, and length of hospitalization. I strive to create lifelong relationships with each of my patients to ensure continued success in achieving excellent medical outcomes and to maximize quality of life.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.